Report: Bally’s Gets $2.07B Buyout Offer; Shares Soar 22.7%

Bally’s Corp. (NYSE: BALY) has received a $2.07 billion buyout offer from its largest shareholder, hedge fund Standard General LP, which already holds a 21% stake in the casino operator, The Wall Street Journal said, citing a filing with the Securities and Exchange Commission.

Bally’s Chairman Soo Kim is the founding partner and Chief Investment Officer of New York-based Standard General, which has offered to pay $38 for each BALY share.

The deal is contingent on the approval of Standard General’s special committee of independent directors and outstanding BALY shareholders.

BALY stock gained 22.7% on Tuesday to close at $35.85. The stock was trading 0.9% up in the pre-market session on Wednesday at the time of writing.

About Bally’s

Based out of Rhode Island, Bally’s is a gaming, betting, and interactive entertainment company. It owns and operates 14 casinos across ten U.S. states, a horse track in Colorado, and has access to online sports betting licenses in 14 states.

Wall Street’s Take

Following the news, Stifel Nicolaus analyst Steven Wieczynski maintained a Buy rating on the stock but did not provide a price target.

Wieczynski finds the offer encouraging and believes it should provide a floor for the company’s valuation even if the deal does not materialize.

Additionally, Jordan Bender of Macquarie reiterated a Buy rating on Bally’s and lowered his price target to $58 from $79 (61.8% upside potential).

Overall, the stock has a Moderate Buy consensus rating based on 5 Buys and 2 Holds. The average Bally’s price forecast of $53.83 implies 50.2% upside potential. Shares have lost 30.1% over the past year.

Blogger Opinions

TipRanks data shows that financial blogger opinions are 66% Bullish on Bally’s, the same as the sector average.

Download the TipRanks mobile app now.

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Read full Disclaimer & Disclosure

Related News:
Pfizer, BioNTech Commence Study of Omicron COVID-19 Vaccine
Understanding MACOM Technology Solutions’ Risk Factors
Walmart Teams Up with Plenty to Create Niche in Vertical Farming